A review of hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome
- PMID: 24959566
- PMCID: PMC4045534
- DOI: 10.1155/2013/784520
A review of hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome
Abstract
Hypothalamic-pituitary-adrenal (HPA) axis dysfunction has been found in a high proportion of chronic fatigue syndrome (CFS) patients and includes enhanced corticosteroid-induced negative feedback, basal hypocortisolism, attenuated diurnal variation, and a reduced responsivity to challenge. A putative causal role for genetic profile, childhood trauma, and oxidative stress has been considered. In addition, the impact of gender is demonstrated by the increased frequency of HPA axis dysregulation in females. Despite the temporal relationship, it is not yet established whether the endocrine dysregulation is causal, consequent, or an epiphenomenon of the disorder. Nonetheless, given the interindividual variation in the effectiveness of existing biological and psychological treatments, the need for novel treatment strategies such as those which target the HPA axis is clear.
Figures
References
-
- Chaudhuri A, Behan PO. Neurological dysfunction in chronic fatigue syndrome. Journal of Chronic Fatigue Syndrome. 2000;6(3-4):51–68.
-
- Ottenweller JE, Sisto SA, McCarty RC, Natelson BH. Hormonal responses to exercise in chronic fatigue syndrome. Neuropsychobiology. 2001;43(1):34–41. - PubMed
-
- Van Houdenhove B, Eede FVD, Luyten P. Does hypothalamic-pituitary-adrenal axis hypofunction in chronic fatigue syndrome reflect a ’crash’ in the stress system? Medical Hypotheses. 2009;72(6):701–705. - PubMed
-
- Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Annals of Internal Medicine. 1994;121(12):953–959. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources